Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Diabetes Care|January 23, 2026
Interlaboratory Evaluation of Multiplex Autoantibody Assay Performance in the Islet Autoantibody Standardization Program 2024 WorkshopIlaria Marzinotto, David L Pittman, Peter Achenbach, et al.
Clinical Chemistry|August 15, 2019
Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay PerformanceVito Lampasona, David L Pittman, Alistair J Williams, et al.
Acta Diabetologica|January 31, 2022
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)Rosaura Casas, Fabrícia Dietrich, Sara Puente-Marin, et al.
Diabetes|October 26, 2011
Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetesMaren Pflueger, Tuulikki Seppänen-Laakso, Tapani Suortti, et al.
Clinical Immunology (Orlando, Fla.)|October 25, 2006
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization ProgramPeter Achenbach, Michael Schlosser, Alistair J K Williams, et al.
Diabetes|May 24, 2015
Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 DiabetesAlistair J K Williams, Vito Lampasona, Rebecca Wyatt, et al.
Clinical Chemistry|October 8, 2011
Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8Vito Lampasona, Michael Schlosser, Patricia W Mueller, et al.
Ebiomedicine|July 8, 2022
A classification and regression tree analysis identifies subgroups of childhood type 1 diabetesPeter Achenbach, Markus Hippich, Jose Zapardiel-Gonzalo, et al.
Clinical Immunology (Orlando, Fla.)|October 6, 2010
A simplified method to assess affinity of insulin autoantibodiesPeter Achenbach, Liang-Hao Guo, Claudia Gick, et al.
Acta Diabetologica|September 6, 2013
Soluble interleukin-2 receptor alpha in preclinical type 1 diabetesStephanie Krause, Andreas Beyerlein, Christiane Winkler, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Diabetes Care|January 23, 2026
Interlaboratory Evaluation of Multiplex Autoantibody Assay Performance in the Islet Autoantibody Standardization Program 2024 WorkshopIlaria Marzinotto, David L Pittman, Peter Achenbach, et al.
Clinical Chemistry|August 15, 2019
Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay PerformanceVito Lampasona, David L Pittman, Alistair J Williams, et al.
Acta Diabetologica|January 31, 2022
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)Rosaura Casas, Fabrícia Dietrich, Sara Puente-Marin, et al.
Diabetes|October 26, 2011
Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetesMaren Pflueger, Tuulikki Seppänen-Laakso, Tapani Suortti, et al.
Clinical Immunology (Orlando, Fla.)|October 25, 2006
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization ProgramPeter Achenbach, Michael Schlosser, Alistair J K Williams, et al.
Diabetes|May 24, 2015
Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 DiabetesAlistair J K Williams, Vito Lampasona, Rebecca Wyatt, et al.
Clinical Chemistry|October 8, 2011
Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8Vito Lampasona, Michael Schlosser, Patricia W Mueller, et al.
Ebiomedicine|July 8, 2022
A classification and regression tree analysis identifies subgroups of childhood type 1 diabetesPeter Achenbach, Markus Hippich, Jose Zapardiel-Gonzalo, et al.
Clinical Immunology (Orlando, Fla.)|October 6, 2010
A simplified method to assess affinity of insulin autoantibodiesPeter Achenbach, Liang-Hao Guo, Claudia Gick, et al.
Acta Diabetologica|September 6, 2013
Soluble interleukin-2 receptor alpha in preclinical type 1 diabetesStephanie Krause, Andreas Beyerlein, Christiane Winkler, et al.
Pageof 11